New York, NY, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The latest research report [115+] pages with 360-degree visibility, titled “Lidocaine Hydrochloride Market Share, Size, Trends, Industry Analysis Report ...

SCHAUMBURG, Ill., August 25, 2025--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced the launch of their first ...

The FDA has released the following: Teligent Pharma, Inc. is voluntarily recalling one lot of Lidocaine HCl Topical Solution 4%, 50ml in a screw cap glass bottle to the user level. The product is ...

Details concerning the Lidocaine Hydrochloride combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, ...

Huons is actively expanding its presence in the global market. The Korean health care company has received approval from the Food and Drug Administration (FDA) 4 years in a row for its injectable ...

The ampules are available immediately. Spectra Medical Devices has received approval from the Food and Drug Administration (FDA) to market Lidocaine HCl Injection USP, 1%, 5mL single use ‘Safety Snap’ ...

Lidocaine hydrochloride is a short-acting amide-type local anesthetic with a rapid onset and short duration of action and contains no preservatives. Sintetica's unique ability to produce sterile ...

Details concerning the Lidocaine Hydrochloride medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and ...

For the second time in just over six weeks, Teligent Pharma recalled Lidocaine HCl Topical Solution 4%, 50ml for super potency. This time, instead of just one lot, Teligent pulled five lots, four ...

RECALLED label. Do not use. Used in recall story. The recalled lot of Lidocaine HCl Topical Solution 4% (40mg/mL) was distributed at the wholesale and retail distribution levels. Teligent Pharma is ...

Marks the first Lidocaine product in Avenacy’s expanding portfolio Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced the launch of their ...